Combining serology & viral nucleic acid tests in a single device, this innovation will facilitate rapid Point-of-Care triage and patient treatment, new biomarker discovery for drug development, and home self tests for health monitoring and remote clinical trials.

Altratech will be exhibiting at BIO2026 in San Diego on 22 - 25 June 2026 on the EU-EIC booth. During the conference, we will present data from a recent pre‑clinical study involving HIV patient samples.